Related Experiment Video
Updated: Jun 24, 2026
03:49
Application of Microwave Ablation in Laparoscopic Partial Splenectomy
Published on: November 15, 2024
Diagnostic splenectomy for visceral leishmaniasis.
H Pickering1, R Bethune, I A Eyre-Brook
1Department of General Surgery, Musgrove Park Hospital, Taunton, UK.
Annals of the Royal College of Surgeons of England
|April 2, 2009
Summary
A rare case of visceral leishmaniasis, a parasitic infection, presented as a diagnostic challenge. Splenectomy revealed the infection, leading to complete recovery with Amphotericin treatment.
Area of Science:
- Tropical medicine
- Parasitology
- Surgical diagnostics
Background:
- Visceral leishmaniasis is a rare parasitic disease presenting with non-specific symptoms.
- Diagnostic challenges arise in endemic and non-endemic regions.
- Pancytopenia and splenomegaly are key clinical indicators.
Observation:
- A 57-year-old man presented with malaise, fever, night sweats, and shortness of breath.
- Initial investigations, including bone marrow aspiration, were inconclusive.
- Clinical deterioration prompted a diagnostic splenectomy.
Findings:
- Histological examination of the spleen confirmed visceral leishmaniasis.
- The patient showed complete recovery following Amphotericin treatment.
Implications:
- This case underscores the diagnostic utility of splenectomy in complex cases.
- It highlights the challenges general surgeons face in diagnosing rare tropical diseases.
- Early recognition and treatment are crucial for favorable outcomes in visceral leishmaniasis.
Related Concept Videos
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...